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Objective: Giant cell tumor of tendon sheath is a rare cause of ulnar tunnel syndrome.
We present a case of a 37-year-old woman who presented with decreased sensation and
weakness of grip of the right hand. Magnetic resonance imaging indicated the presence
of a mass in the hypothenar eminence and showed that the mass was associated with
the flexor carpi ulnaris tendon and displacing the ulnar neurovascular bundle. A differ-
ential diagnosis included desmoid tumor and sarcoma. Methods: Surgical examination
showed a mass that was associated with the flexor carpi ulnaris tendon and flexor reti-
naculum located in the distal portion of Guyon’s canal and intertwined with the ulnar
nerve and displacing the ulnar artery. The mass was removed and Guyon’s canal was
released. Results: Histological examination indicated a diagnosis of giant cell tumor
of tendon sheath (GCTTS). Postoperatively, the patient had fully restored sensory and
motor function of the right hand. Conclusions: Although GCTTS is the most common
solid, soft-tissue lesion of the hand, it is rarely diagnosed properly preoperatively. There-
fore, it is imperative to always include GCTTS in the differential diagnosis of any mass
of the hand.
Giant cell tumor of tendon sheath (GCTTS) is the most common solid, soft-tissue lesion of
the hand.1 It most commonly occurs on the tendon sheath and in the joints of the digits.2−4
It is a benign process that has been known to impinge upon surrounding structures and soft
tissue andmay erode bonystructures as itgrows in a confinedspace.5 The literatureis scant
with descriptions of GCTTS located at the wrist causing ulnar tunnel syndrome.6−11 Any
mass growing within the confined space at Guyon’s canal has the potential to cause nerve
compressionandthusproducesymptomsofulnartunnelsyndrome.Ulnartunnelsyndrome
presents as pain in the wrist and the forearm radiating to the ulnar 2 digits, increased pain at
night exacerbated by exercise or wrist flexion, numbness, tingling, burning, and prickling
in the ulnar 2 digits. It may or may not show weakness and wasting of the intrinsic hand
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musclesinnervatedbytheulnarnerve.12 Wepresentacaseofulnartunnelsyndromecaused
by a localized GCTTS of the hypothenar eminence.
CASE REPORT
A 37-year old, right-hand dominant woman who works as a buyer of candy and tobacco for
awholesaledistributorpresentedwithdecreasedsensationandweaknessofright-handgrip.
Upon examination, a proximal hypothenar fullness was noted. At the time of presentation,
the patient indicated that this fullness has waxed and waned for the past 1 year. Over the
past 6 months the patient had increased numbness and tingling in the ulnar 2 digits and
generalizedweaknessofherrighthand.Ultrasoundexaminationwasperformedandshowed
a solid heterogeneous mass of the hypothenar eminence. A follow-up magnetic resonance
imaging(MRI)noteda2.2×2.4×2-cmbi-lobedmasswithinthehypothenarmusculature,
which appeared to be displacing the ulnar artery and ulnar nerve (Fig 1). Based on this MRI
a differential diagnosis of desmoid versus sarcoma was given by the radiologist. It was,
therefore, determined that incisional or excisional biopsy of the mass would be the most
appropriate course of treatment.
In the operating room under general anesthesia, a 5-cm Brunner’s incision was made
directlyoverGuyon’scanal.Itextended3.5cmdistaland1.5cmproximaltothewristcrease.
The mass was identified and was found to originate at the distal portion of Guyon’s canal,
Figure 1. Sagittal T1-weighted magnetic resonance
image of the right hand showing a giant cell tumor of
tendon sheath involving the ulnar neurovascular bundle
at Guyon’s canal. The red arrow indicates the ulnar neu-
rovascular bundle. The white arrow indicates the mass.
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extending distally into the hypothenar musculature. The mass was intertwined with the
superficial and deep palmar branches of the ulnar nerve proximal to where the deep palmar
branch of the ulnar nerve enters the hypothenar tunnel and was impinging upon the ulnar
artery(Fig2).Sincethediagnosiswasunclear,thehandwasnotforcefullyexsanguinatedand
carewastakentonotdisruptthefascialplanes.Asmallportionofthemasswasexcisedand
sentasafrozensectiontomakethediagnosis.Aftercarefuldissection,thelesionwasfound
to be loosely associated with the undersurface of the flexor carpi ulnaris tendon and more
associated with the flexor retinaculum. Guyon’s canal was released and careful neurolysis
was performed. A 2.5-cm, well-circumscribed, bi-lobed mass was removed and sent for
pathological evaluation, which indicated a GCTTS (Fig 3). Four months postoperatively,
the patient had fully restored sensory and motor function of the right hand (Fig 4).
Figure 2. Operativeviewofthegiantcelltumor
of tendon sheath entangled in the ulnar nerve.
The blue loop is holding the superficial branch
of ulnar nerve. The white arrow indicates the
ulnar artery. The black arrow indicates the ulnar
nerve.
DISCUSSION
Jaffe et al13 first described GCTTS pathologically in 1941. They postulated that this le-
sion has a common histological origin with pigmented villonodular synovitis; the major
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Figure 3. The removed mass.
Figure 4. The patient’s hand postoperatively.
difference being that GCTTS grows outward from the tendon sheath, whereas pigmented
villonodular synovitis grows inward from the synovial lining into the joint. There are 3
main cell types that compose GCTTS; these are multinucleated, osteoclast-like giant cells,
round or polygonal mononuclear cells, and histiocyte-like cells (foam cells).14 All of these
cells contain hemosiderin in their cytoplasm.3 Gross observation shows lesions that can be
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yellow, brown, gray-white, and red. Yellowish lesions are laden with lipid, whereas a brown
colorindicatesapredominanceofiron.Yellowandbrownlesionstendtobeassociatedwith
GCTTS. The gray-white color indicates the presence of fibrous tissue. The red lesions are
typically associated with diffuse pigmented villonodular synovitis.14−16
WhilethepreciseoriginofGCTTSisunknown,ithasbeenassociatedwithmanydiffer-
entprocessesincludinginflammatory,reactive,neoplastic,traumatic,andimmunemediated
causes. However, based on evidence of DNA flow cytometry17, nm23 gene expression,18
and cytogenetic abnormalities19 there is growing evidence that these lesions arise from a
neoplastic origin.
Giant cell tumor of tendon sheath can be localized or diffuse. Most often, localized
GCCTS is well circumscribed by a thin, fibrous capsule and presents as a small (average,
1.1cm),slow-growingmassthatisfirmtothetouch,non-tender,andismostoftenfoundon
tendon sheaths or in the joints of digits.2−4 Diffuse GCTTS is most commonly associated
with the knee and is much less common.4 Pigmented villonodular synovitis is identified by
a diffusely proliferated synovial membrane with villous projections, may or may not have
nodules, and most frequently involves the knee and hip joints. This lesion is usually large
(average, 2 cm) and covered by one or more layers of synovial cells.3,4
The most common benign masses of the hand are ganglion, GCTTS, epidermal inclu-
sion cysts, hemangiomas, fibromas, mucous cysts, and lipomas.20−24 Giant cell tumor of
tendon sheath is the most common solid, soft-tissue lesion of the hand1 and is the second
most common mass of the hand, second to ganglion.1,20,23 Typically, it is more common in
women than men and the mean age of diagnosis is between 30 and 50 years.1,15
To our knowledge, there have been only 5 case reports on GCTTS located at Guyon’s
canal in the English literature6−8,10,11 and 1 in the non-English literature.9 Each case
presented with ulnar tunnel syndrome symptoms. In all cases the lesion was imping-
ing upon the ulnar neurovascular bundle in or around Guyon’s canal, thereby producing
symptoms of ulnar tunnel syndrome. Correct diagnosis was made only upon pathological
evaluation.
The sites of ulnar nerve compression within Guyon’s canal can be classified into
3zones.Zone1islocateddistaltothebifurcationoftheulnarnerveintosuperficialanddeep
palmar branches. Compression of the ulnar nerve in zone 1 can produce complete sensory
andmotordeficits,purelysensoryorpurelymotordeficits.Zone2surroundsthedeepmotor
branch of ulnar nerve. Compression in zone 2 results in paralysis of the intrinsic muscles
and may involve the hypothenar muscles depending upon where the compression occurs
in zone 2. Zone 3 surrounds the superficial branch of ulnar nerve. Compression in zone
3 results in purely sensory deficits.25,26
The most common method for treatment of GCTTS is surgical excision; however, the
average recurrence rate is 26.5% (range, 9%–44%) with an average time of recurrence of
2 years 3 months (range, 3 months to 10 years).27 Recurrence is common if the lesion
is not completely removed. Other factors which increase the rate of recurrence include
multiple primary lesions, tumors involving the thumb, and erosion of the bone.18,23 In
addition to excision of the lesion, release of Guyon’s canal may be indicated to relieve
nerve compression symptoms. The ulnar nerve bifurcates into superficial and deep palmar
branches proximal to Guyon’s canal. The deep palmar branch of the ulnar nerve contin-
ues distally through the hypothenar tunnel, the floor being formed by the piso-hamate
ligament and the roof being formed by tendinous origin of a portion of the hypothenar
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muscles: the adductor digiti minimi, the flexor digiti minimi brevis, and the opponens
digiti minimi muscles.28 It is important to inspect the deep palmar branch as it travels in
the hypothenar tunnel as it may require decompression if the lesion involves the nerve in
this structure. Furthermore, once the lesion is removed, the surrounding area should be
inspected for satellite lesions and if present these should be removed. If osseous erosion has
occurred, removing that part of the cortical shell that has been involved may be indicated
to prevent recurrence. Radiation may play a role in the treatment of GCTTS.14 However,
given the complications of possible hand contracture, radiation is not currently utilized.
With regard to more conservative treatment, GCTTS does not resolve on its own.14 There-
fore, surgical intervention is the only current method of treatment to resolve and relieve
symptoms.
Kitagawa et al29 state that T1- and T2-weighted MR images of GCTTS located in
the hand produce signal intensities between muscle and fat. In addition, they note that the
relatively low signal intensity on T2-weighted images of GCTTS is an important feature
that differentiates it from soft-tissue sarcoma, which usually has a signal intensity equal to
or greater than that of fat on T2-weighted images. Nevertheless, Kittagawa et al speculate
that these MRI findings may apply only to the hand. Other MRI studies that have assessed
GCTTSincludedmorelesionsofthelowerextremity,whereastheKittagawaetalstudywas
composedmainlyofGCTTSofthehand(88%).Toexplainthis,theyincludeafindingfrom
Rao and Vigorita16 that shows that lesions of the fingers have fewer iron deposits. Less iron
serves to shorten the T2-relaxation time due to the magnetic susceptibility effect.16 With
regard to MRI enhancement, De Beuckeleer et al30 report that gadolinium administration
enhances GCTTS due to proliferation of capillaries in the stroma. Moreover, Khan et al31
state that mild-to-moderate diffuse enhancement is helpful in distinguishing GCTTS from
ganglion. Thus, gadolinium enhancement can play an important role in further refining the
diagnosis.
SUMMARY
This case demonstrates that ulnar tunnel syndrome caused by GCTTS is a rare occur-
rence and that it is often misdiagnosed preoperatively. Since GCTTS is the most common
solid, soft-tissue lesion of the hand, it should always be included in the differential di-
agnosis whenever a mass of the hand is presented. Regarding imaging, MRI with and
without enhancement may be useful for diagnosis. Nevertheless, a definitive diagnosis
can be provided only by pathologic evaluation. Surgical removal is the standard treatment
of GCTTS and it is important that the entire lesion be removed. This is crucial to re-
duce chances of lesion recurrence. Lastly, release of Guyon’s canal and the hypothenar
tunnel may be indicated at the time of lesion excision to help relieve nerve compression
symptoms.
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